GL1X · GenesisL1 explorer

MolNFT v1 · #147244 · protein

Structure of wild type human transthyretin in complex with tafamidis

6E6Z: “Structure of wild type human transthyretin in complex with tafamidis”. X-ray diffraction, 1 ligand (3MI), 1 pocket (best druggability 0.30). MolNFT v1 #147244 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6E6Z
Type
protein
Length
230 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
3MI
Pockets
1 · best druggability 0.30

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTransthyretinprotein1157% helix, 53% strandP02766

Ligands and binding sites

  • 3MI · 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1530.300.7614empty

Interfaces

1 interface between chains.

  • A–B · 960 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 6E6Z · Structure of Wild Type Human Transthyretin in Complex with Tafamidis · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.